Ruddington Drug Development Company Gets Bigger

A village based pharmaceutical specialist, which employs almost 400 people at Ruddington Fields Business Park, has just taken over another UK based drug firm for an undisclosed sum. Quotient Sciences, the drug development and manufacturing accelerator, located along Mere Way, has announced that it has acquired Arcinova – described as “a multiservice contract development and manufacturing organization (CDMO).”  Trading for over 40 years and with 160 employees of its own at Alnwick, in Northumberland, Arcinova is said to provide drug substance, drug product and bioanalysis services to over 200 pharma and biotech customers worldwide. In…

Read More

Ruddington’s Role In COVID-19 Treatment

A Ruddington based drug development company has announced a new collaboration which aims to speed up the process of getting a drug to reduce Coronavirus symptoms into human clinical trials. Quotient Sciences, which has its head office at Trent House on Mere Way, and employs around 400 staff, has teamed up with Pittsburgh based CytoAgents, Inc – a privately run American biotechnology company which focuses on the development of pharmaceutical products for the treatment of viral infectious diseases. Scientific consensus is building that severe illness caused by COVID-19 and other infectious diseases is triggered…

Read More

A Bigger Quotient

A Ruddington-based drug development company has announced it’s taken a major step into the American pharmaceuticals market. Quotient Clinical, which has its head office at Trent House on Mere Way and employs around 250 staff, has acquired SeaView Research for an eight-figure sum. The multi-million pound deal sees Quotient expanding its operations into the USA and will see the firms combine their customer portfolios. All new drugs undergo rigorous testing before they can be prescribed or sold and Quotient Clinical has been operating clinical trials with paid volunteers here in Nottinghamshire for around 20 years. During…

Read More